Powder: -20°C for 3 years | In solvent: -80°C for 1 year
NQTrp is an inhibitor of the aggregation of the tau protein with generic anti-amyloidogenic effects.
説明 | NQTrp is an inhibitor of the aggregation of the tau protein with generic anti-amyloidogenic effects. |
In vitro | NQTrp inhibits the in vitro aggregation of hexapeptide (41GCWMLY46 within the N-terminus of γD-crystallin) as well as full-length γD-crystallin. NQTrp effectively inhibits the fibrillation of the GDC6 peptide (50 μM) in a dose-dependent manner and prevents the formation of elongated amyloid fibrils[1]. NQTrp has no toxic effect toward retinal cell culture and reduces the cytotoxicity induced by aggregates of the hexapeptide(IC50=70 μM) in ARPE-19 cells. In TEM analysis, GDC6 peptide fibrils (50 μM) in the presence of NQTrp 5:1, 1:1, 1:5 ratio (GDC6: NQTrp)[1]. |
分子量 | 360.36 |
分子式 | C21H16N2O4 |
CAS No. | 185351-19-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 125 mg/mL (346.88 mM), Sonication and heating to 60℃ are recommended.
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
NQTrp 185351-19-3 Cytoskeletal Signaling Microtubule Associated Microtubule/Tubulin Inhibitor aggregation inhibit fibrils Tau Protein hexapeptide γD-crystallin amyloidogenic inhibitor